Prelude Capital Management’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-40,432
Closed -$722K 1360
2024
Q4
$722K Buy
+40,432
New +$722K 0.05% 395